Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis and supports restoration of the intestinal stem cell niche
V. G. Weis, A. C. Deal, G. Mekkey, C. Clouse, M. Gaffley, E. Whitaker, J. A. Weis, M. Z. Schwartz, A. Atala
This study shows human placental-derived stem cells (hPSC) improve intestinal damage in a NEC rat model by restoring the intestinal stem cell niche.
bioRxiv · Oct 5, 2020 · PreprintCell Biology